Scoulerine hydrochloride

Synonyms: (-)-Scoulerine hydrochloride; Discretamine hydrochloride
Scoulerine ((-)-Scoulerine; Discretamine) hydrochloride 是一种多靶点抑制剂,具有抗肿瘤和抗氧化活性,主要靶向 PI3K/Akt/mTOR 信号轴和 α1D-肾上腺素能受体,破坏微管结构并诱导细胞周期阻滞与凋亡,有效抑制线粒体脱氢酶活性,靶向 GABA 受体和 BACE1,抑制癌细胞的增殖、迁移、侵袭、上皮间质转化及干细胞特性,还具备抗恶性疟原虫、抗菌、止吐镇咳等多重药理活性,并能调节内质网应激及线粒体功能 (调控 Bax、Bcl-2 和细胞色素 c),可用于白血病、卵巢癌及结直肠癌的相关研究。
产品编号: MS-H02078 CAS No.: 51486-68-1 分子式: C19H22ClNO4 分子量: 363.84
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
50mg
询价
询价
100mg
询价
询价

产品描述

Scoulerine ((-)-Scoulerine; Discretamine) hydrochloride 是一种多靶点抑制剂,具有抗肿瘤和抗氧化活性,主要靶向 PI3K/Akt/mTOR 信号轴和 α1D-肾上腺素能受体,破坏微管结构并诱导细胞周期阻滞与凋亡,有效抑制线粒体脱氢酶活性,靶向 GABA 受体和 BACE1,抑制癌细胞的增殖、迁移、侵袭、上皮间质转化及干细胞特性,还具备抗恶性疟原虫、抗菌、止吐镇咳等多重药理活性,并能调节内质网应激及线粒体功能 (调控 Bax、Bcl-2 和细胞色素 c),可用于白血病、卵巢癌及结直肠癌的相关研究。

生物实验数据

生物活性 Scoulerine ((-)-Scoulerine; Discretamine) hydrochloride is a multi-target inhibitor with antitumor and antioxidant activities that primarily targets the PI3K/Akt/mTOR signaling axis and the α1D-adrenergic receptor, disrupts microtubule structure and induces cell cycle arrest and apoptosis, effectively inhibits mitochondrial dehydrogenase activity, targets GABA receptors and BACE1, suppresses cancer cell proliferation, migration, invasion, epithelial-mesenchymal transition and stemness, and also possesses multiple pharmacological activities including anti-Plasmodium falciparum, antibacterial, antiemetic and antitussive effects, and can modulate endoplasmic reticulum stress and mitochondrial function (regulating Bax, Bcl-2 and cytochrome c), making it useful for research related to leukemia, ovarian cancer and colorectal cancer.
IC50 & Target

mTOR

 

Bak

 

BACE1

 

Alpha-1D adrenergic receptor

 

体外研究
(In Vitro)

Scoulerine (1-50 μM;72 h) 对人肺癌 A549 细胞、卵巢癌 A2780 细胞、乳腺癌 SK-BR-3 细胞和 MCF-7 细胞具有抗增殖活性,低浓度 (1 μM、5 μM) 对细胞增殖影响较小或略有延迟,高浓度 (10 μM、20 μM、50 μM) 则显著抑制细胞增殖。
Scoulerine (2.5-20 μM;24 h) 诱导 Jurkat 和 MOLT-4 白血病细胞凋亡,早期和晚期凋亡率均呈剂量依赖性增加,且能通过 TUNEL assay 检测到 DNA 片段化。

Cell Viability AssayWestern Blot AnalysisCell Proliferation AssayApoptosis AnalysisCell Cytotoxicity AssayCell Cycle AnalysisRT-PCRCell Autophagy AssayImmunofluorescenceCell Differentiation AssayCell Invasion AssayCell Migration Assay Real Time qPCRELISA Assay

Cell Line: Jurkat, MOLT-4, Raji, HL-60, U-937, HEL 92.1.7, A549, A2780, SK-BR-3, MCF-7
Concentration: 1 μM, 5 μM, 10 μM, 15 μM, 20 μM, 50 μM
Incubation Time: 24 h, 48 h, 72 h
Result: Reduced the viability and proliferation of leukemic cells in a dose-dependent manner within 24 h, and the reduction was more pronounced at 48 h.
For adherent cell lines, low concentrations (1 μM, 5 μM) had no significant effect or slightly delayed proliferation, while high concentrations (10 μM, 20 μM, 50 μM) exerted a potent antiproliferative effect over 72 h.
The IC50 values of scoulerine against human leukemic cells ranged from 2.7 to 6.5 μM as determined by XTT assay.
IC50 values: 2.7 ± 0.1 μM (Jurkat), 4.2 ± 0.2 μM (HL-60), 4.7 ± 0.2 μM (MOLT-4), 4.8 ± 0.3 μM (U-937), 6.3 ± 0.8 μM (HEL 92.1.7), 6.5 ± 0.7 μM (Raji).

Cell Viability AssayWestern Blot AnalysisCell Proliferation AssayApoptosis AnalysisCell Cytotoxicity AssayCell Cycle AnalysisRT-PCRCell Autophagy AssayImmunofluorescenceCell Differentiation AssayCell Invasion AssayCell Migration Assay Real Time qPCRELISA Assay

Cell Line: A549
Concentration: 5 μM, 10 μM, 20 μM
Incubation Time: 24 h
Result: Disrupted the microtubule structure at 10 μM and 20 μM, leading to dense aggregation of microtubules around cell nuclei and reduced density at the cell periphery.
At 5 μM, the tubulin network remained almost intact similar to the control cells.

化学信息

分子量 363.84
分子式 C19H22ClNO4
CAS No. 51486-68-1
别名 (-)-Scoulerine hydrochloride; Discretamine hydrochloride

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础